≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Anti-inflammatory and antirheumatic products, non-steroids

PheWeb

RX_NSAID

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC M01A

326220

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

269715

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

269715

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

269715

diagram downward connector
RX_NSAID

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 269715 159086 110629
Unadjusted prevalence (%) 75.81 80.18 70.30
Mean age at first event (years) 40.31 37.83 43.87

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 0.78 [0.72, 0.85] 2.0e-9 21988
15 years 0.01 0.57 [0.54, 0.61] 2.2e-62 9795
5 years 0.00 0.57 [0.53, 0.61] 2.6e-58 2189
1 year 0.00 0.62 [0.54, 0.71] 1.3e-12 420

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_NSAID – Anti-inflammatory and antirheumatic products, non-steroids
GWS hits:

Survival analyses between endpoints

↥

Plot

before Anti-inflammatory and antirheumatic products, non-steroids
after Anti-inflammatory and antirheumatic products, non-steroids

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Anti-inflammatory and antirheumatic products, non-steroids

↥